Filter
65
Filtered Results: 65
Text search:
antivenoms
Featured
Recommendations
6
New Publications
17
Language
Document type
No document type
21
Guidelines
20
Studies & Reports
13
Strategic & Response Plan
7
Manuals
3
Resource Platforms
1
Countries / Regions
Global
10
Ethiopia
4
India
4
Burkina Faso
3
Rwanda
2
Congo, Democratic Republic of
2
Indonesia
2
Chile
1
Cameroon
1
Peru
1
Morocco
1
Philippines
1
Asia
1
Paraguay
1
Bangladesh
1
South Africa
1
Papua New Guinea
1
Brazil
1
Central African Republic
1
Chad
1
Botswana
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
13
Snakebites
10
Guidelines
10
NTDs & Others
7
Policies
4
COVID-19
3
Clinical Guidelines
3
Countries
2
Non-communicable Diseases
2
Communicable Diseases
1
Paediatrics
1
Pharmacy & Technology
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
Pediatrics
1
Policies & Guidelines HIV & TB
1
Studies & Reports
1
Respiratory Infections
1
Immunization
1
General Guidelines
1
Communicable Diseases
1
Health Systems
1
Leprosy
1
Neonatal Care
1
Toolboxes
Snakebite envenoming
10
Essential Medicines & Devices Lists
6
Country specific documents
3
Essential Medicines
3
Overview, Studies & Reports
3
Traditional & Herbal Medicines
2
One Health
2
Local Action
1
Introduction to Global Health
1
Concepts of Global Health
1
Curricula & Core Competencies
1
Paediatrics
1
Chile
1
Falsified & Substandard
1
Model Formulary
1
Rational use of Medicine
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
NTDs General
1
Article published in: Journal of Intensive Care (2015) 3:16
Snakebites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snakebite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mortal...
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduced by 50% before 2030. For this to be achieved, four strategic aims will be pursued.
Empower and engage communities,
Ensure safe, effective tre...
Standard Treatment Guideline
Management of Snake Bite. Quick Reference Guide
recommended
Standard Treatment Guideline
Replacement of Annex 2 of WHO Technical Report Series, No. 964...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
La presente publicación describe la evidencia científica disponible sobre la precisión diagnóstica de las pruebas rápidas de detección de antígenos para SARS-COV-2. El conocimiento de las pruebas diagnósticas para el coronavirus del síndrome respiratorio agudo grave 2 (SARS-COV-2) sigue evo...
La técnica diagnóstica ampliamente usada a nivel mundial corresponde a la Prueba de Tuberculina o test de Mantoux, la que a través de la inyección de antígenos de Micobacterium tuberculosis permite medir la reacción del individuo y estimar su probabilidad de infección. El presente manual tie...
Snakebite envenoming is a neglected tropical disease (NTD) that is responsible for enormous suffering, disability and premature death on every continent. As over 5.8 billion people are at risk of encountering a venomous snake, it is not surprising but no less tragic that almost 7400 people every
da...
Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co...
In one of his final essays, statesman and former United Nations secretary general Kofi Annan said, ‘Snakebite is the most important tropical disease you’ve never heard of’. Mr. Annan firmly believed that victims of snakebite envenoming should be recognised and afforded greater efforts at impro...
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
As part of its 2019–2030 global strategy for the prevention and control of snakebite envenoming, WHO is launching a new Snakebite Information and Data Platform. This is the result of collaboration between the Departments of Control of Neglected Tropical Diseases (WHO/NTD) and Data Delivery for Imp...
Snakebite envenoming is a potentially life-threatening disease that typically results from the injection of a mixture of different toxins (“venom”) following the bite of a venomous snake. Envenoming can also be caused by venom being sprayed into a person’s eyes by certain species of snakes tha...
Snakebite envenoming affects millions of people worldwide annually and is a significant source of mortality. Preventing and treating the problem is complex and requires collaboration among the fields of public health, medicine, ecology, and laboratory science. After being removed from the category A...
Snakebite envenoming is a serious public health problem in Central America, where approximately 5,500 cases occur every year. Panama has the highest incidence and El Salvador the lowest. The majority, and most severe, cases are inflicted by the pit viper Bothrops asper (family Viperidae), locally kn...
Snake-bites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snake-bite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mort...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
